From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Supplement
Last verified
June 4, 2026
ContraindicatedEmerging evidence
What is happening. Berberine can lower glucose and IGF-1 LR3 may cause insulin-like glucose lowering, increasing hypoglycemia risk.
Mechanism. Additive glucose-lowering through AMPK and insulin/IGF receptor-related pathways.
Recommendation. Do not combine; avoid human IGF-1 LR3 use altogether.
Stack Score
How it moves the number.
Effect on the composite score
If both Berberine and IGF-1 LR3 (Long R3 IGF-1) are in the same stack, this pair applies −25 to your Stack Score (per scored contraindication row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1Owens PC et al. Long R3 IGF-I animal endocrine study. J Endocrinol. 1998.Needs sourceNo link